​

Funding Round

Series A - Obsidian Therapeutics

Series A - Obsidian Therapeutics

Investment Firm

Overview

Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.

Announced Date

Dec 06, 2017

Funding Type

Series A

Highlights

N/A

Location

N/A

Social

N/A

Investor Lead

Google Ventures

Google Ventures

Google Ventures is a convertible_note and crowdfunding and early_stage_venture and late_stage_venture and post_ipo and private_equity and seed and venture firm.

Participant Investors

8

Investor Name
Participant InvestorVertex Pharmaceuticals
Participant InvestorShangPharma
Participant InvestorAtlas Venture
Participant InvestorGoogle Ventures
Participant InvestorVertex Ventures

Round Details and Background

Obsidian Therapeutics raised $49500000 on 2017-12-06 in Series A

Obsidian Therapeutics is a developer of a next-generation cell and gene therapies created to extend adoptive immunotherapy.

Company Funding History

3

Announcment DateTransaction NameNumber Of InvestorsLead InvestorMoney Raised
Dec 06, 2017
Series A - Obsidian Therapeutics
9-49.5M
Sep 09, 2021
Series B - Obsidian Therapeutics
14-115.0M
Apr 03, 2024
Series C - Obsidian Therapeutics
17-160.5M

Recent Activity

There is no recent news or activity for this profile.